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Introduction 
Aerobic fitness (represented by VO2peak), derived from cardiopulmonary exercise 
testing (CPET), is a biomarker predictive of mortality in interstitial lung disease (ILD). 
However, CPET requires elicitation of maximal responses, which may not be feasible 
for some patients due to clinical contraindications. Therefore, suitable submaximal 
exercise-based biomarkers are required. The oxygen uptake efficiency plateau 
(OUEP), defined as a 90 second average of oxygen uptake relative to minute 
ventilation (VO2/VE), is one submaximal parameter that has been previously 
investigated in patients with cystic fibrosis and heart failure. Currently, there are no 
data for ILD. 
Objectives 
To determine if OUEP is a viable biomarker in ILD by 1) characterising OUEP in a 
cohort of patients with ILD, and 2) establishing relationships between traditional 
pulmonary function biomarkers (FVC and DLCO), OUEP and VO2peak 
Methods 
24 participants with ILD (69.7 ± 7.6 years) underwent CPET, via cycle ergometry, to 
identify VO2peak and OUEP. Pulmonary function data were retrospectively obtained 
from patient records. OUEP as a percentage of time to exhaustion (TTE), and VO2peak 
were identified. Pearson’s correlation coefficients were established between VO2peak, 
OUEP, FVC and DLCO.  
Results 
21 participants (15 male/6 female) produced a valid CPET as per existing guidelines. 
Mean (± standard deviation) VO2peak and OUEP were 1.40 ± 0.36 L.min-1 and 27.4 ± 
4.6 mL.L-1 respectively. OUEP occurred at 37 ± 22 % of TTE, representing 60.1 ± 14.0 
% VO2peak. FVC held non-significant correlations with VO2peak (r = 0.16, p = 0.48) and 
OUEP (r = 0.31, p = 0.17). In contrast, DLCO held significant and stronger correlations 
with both VO2peak (r = 0.59, p =0.006) and OUEP (r = 0.71, p < 0.001). VO2peak and 
OUEP significantly correlated with one another (r = 0.73, p < 0.001).  
Conclusions 
OUEP was successfully determined and identified in all participants. It correlated 
highly with VO2peak, the current gold-standard measure from CPET. It also correlated 
highly with DLCO, to a greater magnitude than VO2peak. As OUEP occurred at 
~60%VO2peak, it is submaximal in nature, and may therefore be a viable biomarker in 
ILD, particularly for those patients who cannot exercise to volitional maximal 
exhaustion.  
